Smith+Nephew to Announce Q2 and H1 2025 Results on August 5

Smith+Nephew to announce Q2 and H1 2025 results on August 5. The company, a global medical technology firm, operates in three main business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The results will be followed by a conference call for financial analysts, highlighting the company's commitment to transparency and engagement with stakeholders.

Smith+Nephew, a global medical technology firm, is set to release its second quarter (Q2) and first half (H1) 2025 financial results on Tuesday, August 5, 2025. The company, headquartered in London, specializes in orthopedics, sports medicine, ENT (ear, nose, and throat), and advanced wound management. The results will cover the period ended June 28, 2025 [1].

Following the announcement, Smith+Nephew will host a conference call for financial analysts at 8:30am BST (2:00am EDT) on the same day. This event underscores the company's commitment to transparency and engagement with stakeholders [2].

Smith+Nephew operates in approximately 100 countries, with a workforce of 17,000 employees. In 2024, the company reported annual sales of $5.8 billion, focusing on medical technology for the repair, regeneration, and replacement of soft and hard tissue [1].

The company is listed on both the London Stock Exchange (LSE:SN) and the New York Stock Exchange (NYSE:SNN). Smith+Nephew is also a constituent of the FTSE 100 index [1].

References:
[1] https://za.investing.com/news/company-news/smithnephew-to-announce-q2-and-h1-2025-results-on-august-5-93CH-3796504
[2] https://www.investing.com/news/company-news/smithnephew-to-announce-q2-and-h1-2025-results-on-august-5-93CH-4143456